| Product NDC: | 64193-244 | 
| Proprietary Name: | Bebulin | 
| Non Proprietary Name: | COAGULATION FACTOR IX HUMAN | 
| Active Ingredient(s): | & nbsp; COAGULATION FACTOR IX HUMAN | 
| Administration Route(s): | |
| Dosage Form(s): | KIT | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 64193-244 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | BLA103112 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 20110316 | 
| Package NDC: | 64193-244-02 | 
| Package Description: | 1 KIT in 1 CARTON (64193-244-02) * 1 VIAL, GLASS in 1 CARTON > 20 mL in 1 VIAL, GLASS * 20 mL in 1 VIAL, GLASS (0338-0764-62) | 
| NDC Code | 64193-244-02 | 
| Proprietary Name | Bebulin | 
| Package Description | 1 KIT in 1 CARTON (64193-244-02) * 1 VIAL, GLASS in 1 CARTON > 20 mL in 1 VIAL, GLASS * 20 mL in 1 VIAL, GLASS (0338-0764-62) | 
| Product NDC | 64193-244 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | COAGULATION FACTOR IX HUMAN | 
| Dosage Form Name | KIT | 
| Route Name | |
| Start Marketing Date | 20110316 | 
| Marketing Category Name | BLA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |